Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] - N0000193913

Pharmacologic Class Information

Pharmacologic Code N0000193913
Pharmacologic Name Adenosine Triphosphate-Citrate Lyase Inhibitor
Pharmacologic Uses
  • adenosine triphosphate-citrate lyase (ACL) inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Adenosine Triphosphate-Citrate Lyase Inhibitor

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
72426-118Nexletol Non-Proprietary Name: Bempedoic AcidTablet, Film CoatedOralEsperion Therapeutics, Inc.ACTIVE
72426-818Nexlizet Non-Proprietary Name: Bempedoic Acid And EzetimibeTablet, Film CoatedOralEsperion Therapeutics, Inc.ACTIVE